Trials / Completed
CompletedNCT02550171
BioGene Bank Cohort Study for Approved Research Requests
The BioGene Bank Cohort Study is a Collection of Human Blood Samples (DNA and Plasma) Along With De-identified (Coded) Health Information, Questionnaire Responses on Environment and History of Family Disease to be Used for Research
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 7,056 (actual)
- Sponsor
- Northwell Health · Academic / Other
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Accepted
Summary
The BioGene bank: Is a centralized collection of human blood samples along with de-identified (coded) health information, environmental factors, family disease histories and information from DNA. Limited to the NSLIJHS catchment area.
Detailed description
The purpose of the BioGene Bank Cohort is to collect blood and store DNA from blood, along with health information to study how genetic variation in the population is associated with particular diseases, treatments and medical outcomes. Investigators may study the entire range of diseases and medical problems that exist within the NSLIJHS, including medical, surgical, psychiatric, pediatric and obstetric conditions. The specimens and medical information will be kept at a central Biorepository. This research study does not involve any treatment and individual research results are not provided.
Conditions
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2015-09-15
- Last updated
- 2016-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02550171. Inclusion in this directory is not an endorsement.